174
Views
1
CrossRef citations to date
0
Altmetric
Clinical features - Original research

Medication non-adherence and the achievement of therapeutic goals of anemia therapy among hemodialysis patients in Jordan

ORCID Icon, , , ORCID Icon &
Pages 82-88 | Received 18 Oct 2021, Accepted 19 Jan 2022, Published online: 31 Jan 2022

References

  • Levey AS, De Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO. Controversies Conference report. 2011;80(1):17–28.
  • Stauffer ME, Fan T, Moura IC. Prevalence of anemia in chronic kidney disease in the United States. PloS One. 2014;9(1):e84943.
  • Garlo K, Williams D, Lucas L, et al. Severity of anemia predicts hospital length of stay but not readmission in patients with chronic kidney disease: a retrospective cohort study. Medicine (Baltimore). 2015 Jun;94(25):e964.
  • Kuo KL, Hung SC, Tseng WC, et al. Association of anemia and iron parameters with mortality among patients undergoing prevalent hemodialysis in Taiwan: the AIM - HD study. J Am Heart Assoc. 2018 Aug 7 7(15):e009206.
  • Drueke TB, Massy ZA. Oral or intravenous iron for anemia correction in chronic kidney disease? Kidney Int. 2015 Oct;88(4):673–675.
  • Chakrabarti S. What’s in a name? Compliance, adherence and concordance in chronic psychiatric disorders. World J Psychiatry. 2014 Jun 22; 4(2):30–36.
  • Marin JG, Beresford L, Lo C, et al. Prescription patterns in dialysis patients: differences between hemodialysis and peritoneal dialysis patients and opportunities for deprescription. Can J Kidney Health Dis. 2020;7:2054358120912652.
  • Wimmer BC, Cross AJ, Jokanovic N, et al. Clinical outcomes associated with medication regimen complexity in older people: a systematic review. J Am Ger Soc. 2017;65(4):747–753.
  • Aspden T, Wolley MJ, Ma TM, et al. Understanding barriers to optimal medication management for those requiring long-term dialysis: rationale and design for an observational study, and a quantitative description of study variables and data. BMC Nephrol. 2015 Jul 11;16:102.
  • Chowdhury R, Khan H, Heydon E, et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J. 2013 Oct;34(38):2940–2948.
  • Iuga AO, McGuire MJ. Adherence and health care costs. Risk management and healthcare policy. Risk Manag Healthc Policy. 2014;7:35–44.
  • de Terline D M, Kane A, Kramoh KE, et al. Factors associated with poor adherence to medication among hypertensive patients in twelve low and middle income Sub-Saharan countries. PloS One. 2019;14(7):e0219266.
  • Ghimire S, Castelino RL, Lioufas NM, et al. Nonadherence to medication therapy in haemodialysis patients: a systematic review. PloS One. 2015;10(12):e0144119.
  • Muntner P, Judd SE, Krousel-Wood M, et al. Low medication adherence and hypertension control among adults with CKD: data from the REGARDS (Reasons for geographic and racial differences in stroke) study. Am J Kidney Dis. 2010 Sep;56(3):447–457.
  • Schmitt KE, Edie CF, Laflam P, et al. Adherence to antihypertensive agents and blood pressure control in chronic kidney disease. Am J Nephrol. 2010;32(6):541–548.
  • Gincherman Y, Moloney K, McKee C, et al. Assessment of adherence to cinacalcet by prescription refill rates in hemodialysis patients. Hemodialysis International. International Symposium on Home Hemodialysis. 2010;14(1):68–72.
  • Nabolsi MM, Wardam L, JOJIjonp A. Quality of life, depression, adherence to treatment and illness perception of patients on haemodialysis. Int J nursing pract. 2015;21(1):1–10.
  • Locatelli F, Barany P, Covic A, et al. Kidney disease: improving global outcomes guidelines on anaemia management in chronic kidney disease: a European renal best practice position statement. Nephrol Dialysis Trans. 2013 Jun;28(6):1346–1359.
  • Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986 Jan;24(1):67–74.
  • De Las Cuevas C, Penate W. Psychometric properties of the eight-item Morisky Medication Adherence Scale (MMAS-8) in a psychiatric outpatient setting. Int J clin health psychol: IJCHP. 2015 May-Aug; 15(2):121–129.
  • Jarab AS, Almrayat R, Alqudah S, et al. Predictors of non-adherence to pharmacotherapy in patients with type 2 diabetes. Int J Clin Pharm. 2014 Aug;36(4):725–733.
  • Parker K, Bull-Engelstad I, Aasebø W, et al. Medication regimen complexity and medication adherence in elderly patients with chronic kidney disease. Hemodial Int Symp Home Hemodial. 2019 Jul;23(3):333–342.
  • Steiner JF, AVJJoce P. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50(1):105–116.
  • EuroQol Research Foundation. EQ-5D-5L user guide, 2019. [cited 2021 Oct 18]. Available from: https://euroqol.org/publications/user-guides.
  • Bjelland I, Dahl AA, Haug TT, et al. The validity of the hospital anxiety and depression scale: an updated literature review. J Psychosom Res. 2002;52(2):69–77.
  • Hemmelgarn BR, Manns BJ, Quan H, et al. Adapting the Charlson Comorbidity Index for use in patients with ESRD. Am J Kidney Dis. 2003 Jul;42(1):125–132.
  • Alkatheri AM, Alyousif SM, Alshabanah N, et al. Medication adherence among adult patients on hemodialysis. Saudi journal of kidney diseases and transplantation: an official publication of the Saudi Center for Organ Transplantation. Saudi Arabia. 2014 Jul 25;4:762–768.
  • Neri L, Martini A, Andreucci VE, et al. Regimen complexity and prescription adherence in dialysis patients. Am J Nephrol. 2011;34(1):71–76.
  • Browne T, Merighi JR. Barriers to adult hemodialysis patients’ self-management of oral medications. Am J Kidney Dis. 2010 Sep;56(3):547–557.
  • Umeukeje EM, Mixon AS, Cavanaugh KL. Phosphate-control adherence in hemodialysis patients: current perspectives. Patient Prefer Adherence. 2018;12:1175–1191.
  • Schmid H, Hartmann B, Schiffl H. Adherence to prescribed oral medication in adult patients undergoing chronic hemodialysis: a critical review of the literature. Eur J Med Res. 2009 May 14; 14(5):185–190.
  • Khalil AA, Darawad M, Al Gamal E, et al. Predictors of dietary and fluid non‐adherence in Jordanian patients with end‐stage renal disease receiving haemodialysis: a cross‐sectional study. Journal of Clinical Nursing. 2013;22(1–2):127–136.
  • Mechta Nielsen T, Frøjk Juhl M, Feldt-Rasmussen B, et al. Adherence to medication in patients with chronic kidney disease: a systematic review of qualitative research. Clin Kidney J. 2018 Aug;11(4):513–527.
  • Chan YM, Zalilah MS, Hii SZ. Determinants of compliance behaviours among patients undergoing hemodialysis in Malaysia. PloS One. 2012;7(8):e41362.
  • Ossareh S, Tabrizian S, Zebarjadi M, et al. Prevalence of depression in maintenance hemodialysis patients and its correlation with adherence to medications. Iran J Kidney Dis. 2014 Nov;8(6):467–474.
  • Nagasawa H, Tachi T, and Sugita I, et al. The effect of quality of life on medication compliance among dialysis patients [Original Research]. 2018 2018 Jun 05;9(488):1-11.
  • Tangkiatkumjai M, Walker DM, Praditpornsilpa K, et al. Association between medication adherence and clinical outcomes in patients with chronic kidney disease: a prospective cohort study. Clin Exp Nephrol. 2017 Jun;21(3):504–512.
  • Roggeri A, Conte F, Rossi C, et al. Cinacalcet adherence in dialysis patients with secondary hyperparathyroidism in Lombardy Region: clinical implications and costs. Drugs Context. 2020;9:1–10.
  • Finkelstein FO, Story K, Firanek C, et al. Health-related quality of life and hemoglobin levels in chronic kidney disease patients. Clin J Am Soc Nephrol. 2009 Jan;4(1):33–38.
  • Johansen KL, Finkelstein FO, Revicki DA, et al. Systematic review of the impact of erythropoiesis-stimulating agents on fatigue in dialysis patients. Nephrol Dialysis Transplantation. 2011;27(6):2418–2425.
  • Johansen KL, Finkelstein FO, Revicki DA, et al. Systematic review and meta-analysis of exercise tolerance and physical functioning in dialysis patients treated with erythropoiesis-stimulating agents. Am J Kidney Dis. 2010 Mar;55(3):535–548.
  • Yang F, Griva K, Lau T, et al. Health-related quality of life of Asian patients with end-stage renal disease (ESRD) in Singapore. Qual Life Res. 2015 Sep;24(9):2163–2171.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.